Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received July 2, 2021
- Accepted August 23, 2021
- Published online September 16, 2021.
Article Versions
- You are currently viewing a previous version of this article (September 16, 2021 - 08:21).
- View the most recent version of this article
Copyright & Usage
Copyright ©The authors 2021. For reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Thomas Gaisl1,
- Chris D. Turnbull2,3,
- Gerrit Weimann4,
- Sigrun Unger5,
- Rudolf Finger5,
- Charles Xing6,
- Peter A. Cistulli7,8,
- Sophie West9,
- Alan K.I. Chiang10,
- Danny J. Eckert11,
- John R. Stradling2,3 and
- Malcolm Kohler1,12⇑
- 1Sleep Disorders Center and Pulmonary Division, University Hospital Zurich, Zurich, Switzerland
- 2National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
- 3Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
- 4Clinical Experimentation, Pharma Research Center, Bayer Pharma, Wuppertal, Germany
- 5Clinical Operations, Pharma Research Center, Bayer Pharma, Wuppertal, Germany
- 6Global Development, Bayer Healthcare Company, Beijing, China
- 7Sleep Research Group, Charles Perkins Centre, Faculty of Medicine and Health, University of Sydney, Sydney, Australia
- 8Department of Respiratory and Sleep Medicine, Centre for Sleep Health and Research, Royal North Shore Hospital, Sydney, Australia
- 9Newcastle Regional Sleep Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
- 10Neuroscience Research Australia (NeuRA), Sydney, Australia
- 11Adelaide Institute for Sleep Health, Flinders health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, Australia
- 12Zurich Center for Interdisciplinary Sleep Research, University of Zurich, Zurich, Switzerland
- Malcolm Kohler (malcolm.kohler{at}usz.ch)
Funding
Bayer HealthCare
Article usage
Altmetrics
Vol 59 Issue 5
Table of Contents
BAY 2253651 for the treatment of obstructive sleep apnea: a multi-center, double-blind, randomized controlled trial (SANDMAN)
